Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).
Clinical trial NCT06623409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06623409
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-12
- Primary completion
- 2026-11-20
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.